Table 1.

Characteristics and proportion of breast centres reporting the provision of active follow-up to breast cancer patients in their catchment area and, specifically, of a screening-led active follow-up (n = 82)

Breast centre characteristic	Total no.	Time interval since diagnosis
		< 5 years		5–10 years		> 10 years
		Active FU, no. (%)a	Screening-led active FU, no. (%)a	Active FU, no. (%)	Screening-led active FU, no. (%)	Active FU, no. (%)	Screening-led active FU, no. (%)
Geographic area
North	53	40 (75)	2 (4)	40 (75)	4 (8)	35 (66)	9 (17)
Centre	19	11 (58)	0 (0)	11 (58)	0 (0)	11 (58)	4 (21)
South	10	5 (50)	0 (0)	5 (50)	0 (0)	3 (30)	1 (10)
Hospital classification
Public hospital	52	37 (71)	2 (4)	36 (69)	3 (6)	33 (63)	10 (19)
Private accredited hospital	5	4 (80)	0 (0)	4 (80)	1 (20)	4 (80)	1 (20)
IRCCS and AOU	14	7 (50)	0 (0)	7 (50)	0 (0)	7 (50)	3 (21)
Private accredited IRCCS	11	8 (73)	0 (0)	9 (82)	0 (0)	5 (45)	0 (0)
No. of new BC cases per yearb
< 345	41	29 (71)	2 (5)	30 (73)	3 (7)	28 (68)	7 (17)
≥ 345	41	27 (66)	0 (0)	26 (63)	1 (2)	21 (51)	7 (17)
No. of mammograms per yearb
< 15,000	42	25 (60)	0 (0)	26 (62)	2 (5)	21 (50)	5 (12)
≥ 15,000	40	31 (78)	2 (5)	30 (75)	2 (5)	28 (70)	9 (23)
BCCert certification
No	58	36 (62)	2 (3)	36 (62)	3 (5)	33 (57)	12 (21)
Yes	24	20 (83)	0 (0)	20 (83)	1 (4)	16 (67)	2 (8)

BC Breast cancer, BCCert European Society of Breast Cancer Specialists’ Breast Centres Certification, FU follow-up, IRCCS Istituto di Ricovero e Cura a Carattere Scientifico (non-University Research Hospital), AOU Azienda Ospedaliero-Universitaria (University Hospital)

^aNon-responses on the presence of active follow-up and on the role of the screening programme were pooled with negative responses

^bDichotomised by the median value